Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose intravenous methylprednisolone in early systemic sclerosis
2015-004613-24Phase 4Completed
- Sponsor
- Radboudumc
- Start
- Apr 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in systemic sclerosis (SSc) comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Change in capillary density. Started Apr 2016; status: completed.
02
Drugs
methylprednisolone
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2015-004613-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004613-24.